116
Views
25
CrossRef citations to date
0
Altmetric
Review

Umbilical cord stem cell transplantation for primary immunodeficiencies

&
Pages 555-565 | Published online: 17 May 2006

Bibliography

  • LEVY J, ESPANOL-BOREN T, THOMAS C et al.: Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. (1997) 131:47-54.
  • WINKELSTEIN JA, MARINO MC, JOHNSTON RB JR et al.: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 79:155-169.
  • ANTOINE C, MULLER S, CANT A et al.: Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet (2003) 361:553-560.
  • MULLER SM, KHON T, SCHULZ AS, DEBATIN KM, FRIEDRICH W: Similar pattern of thymic-dependent T cell reconstitution in infants with severe combined immunodeficiency after human leukocyte antigen (HLA)-identical and HLA-non identical stem cell transplantation. Blood (2000) 96:4344-4349.
  • GLUCKMAN E, BROXMEYER HA, AUERBACK AD et al.: Hematopoietic reconstitution in a patient with Fanconi anaemia by means of umbilical cord blood from an HLA identical sibling. N. Engl. J. Med. (1989) 321:1174-1178.
  • COHEN Y, NAGLER A: Umbilical cord blood transplantation – how, when and for whom? Blood (2004) 18:167-179.
  • WAGNER JE, BARKER JN, DEFOR TE et al.: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non-malignant diseases: influence of CD34 cell dose and HLA disparity on treatment related mortality and survival. Blood (2002) 100:1611-1618.
  • GLUCKMAN E, KOEGLER G, ROCHA V: Human leukocyte antigen matching in cord blood transplantation. Semin. Haematol. (2005) 42:85-90.
  • KOBYLKA P, IVANYI P, BREUR-VRIESENDORP BS: Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells. Transplantation (1998) 65:1275-1278.
  • GLUCKMAN E, ROCHA V, CHEVRET S: Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfusion Clin. Biol. (2001) 8:146-154.
  • BEJZAD-BEHBAHANI A, POURANSAR R, TABEI SZ et al.: Risk of viral transmission via bone marrow progenitor cells versus umbilical cord blood hematopoietic stem cells in bone marrow transplantation. Transplant. Proc. (2005) 37:3211-3212.
  • ROCHA V, JOHN MD, WAGNER JE JR et al.: Graft versus host disease in children who have received a cord blood or bone marrow transplant from an HLA identical sibling. N. Engl. J. Med. (2000) 342:1846-1854.
  • KAMINSKI BA, KADEREIT S, MILLER RE et al.: Reduced expression of NFAT-associated genes in UCB versus adult CD4+ T lymphocytes during primary stimulation. Blood (2003) 102:4608-4617.
  • DAVEY S: The London Cord Blood Bank Analysis of Banking and Transplantation Outcome. Br. J. Haematol. (2004) 125:358-365.
  • NOTARO R, CIMMINO A, TABARINI D, ROTOLI B, LUZZATTO L: In vivo telomere dynamics of human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA (1997) 94:13782-13785.
  • SLATTER MA, BHATTACHARYA A, ABINUN M, FLOOD TJ, CANT AJ, GENNERY AR: Outcome of boost haematopoietic stem cell transplant for decreased donor chimerism or graft dysfunction in primary immunodeficiency. Bone Marrow Transplant. (2005) 35:683-689.
  • BENITO AI, DIAZ MA, CONZALEZ-VICENT M, SEVILLA J, MADERO L: Hematopoietic stem cell transplantation using umbilical cord blood progenitors: review of current clinical results. Bone Marrow Transplant. (2004) 33:765-690.
  • GLUCKMAN E, ROCHA V, ARCESE W et al.: Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp. Hematol. (2004) 32:397-407.
  • TALVENSAARI K, CLAVE E, DOUAY C et al.: A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood (2002) 99:1458-1464.
  • SERRA IB, OLIVERAS TO, LOPEZ LM et al.: Transplante de progenitors hematopoyéticos de sangre de cordon umbilical en ninos. An. Esp. Pediatr. (2000) 53:513-519.
  • BONDUEL M, DEL POZO A, ZELAXKO M et al.: Successful related umbilical cord blood transplantation for graft failure following T cell-depleted non-identical bone marrow transplantation in a child with major histocompatibility complex class II deficiency. Bone Marrow Transplant. (1999) 24:437-440.
  • TOREN A, NAGLER A, AMARIGLIO N et al.: Successful human umbilical cord blood stem cell transplantation without conditioning in severe combined immune deficiency. Bone Marrow Transplant. (1999) 23:405-408.
  • FAGIOLI F, BIASIN E, BERGER M et al.: Successful unrelated cord blood transplantation in two children with severe combined immunodeficiency syndrome. Bone Marrow Transplant. (2003) 31:133-136.
  • KNUTSEN AP, WALL DA: Umbilical cord blood transplantation in severe T cell immunodeficiency disorders: two year experience. J. Clin. Immunol. (2000) 20:446-476.
  • MYERS LA, MICHAEL S, HERSHFIELD MD et al.: Purine nucleoside phosphorylase deficiency (PNP-DEF) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J. Pediatr. (2004) 145:710-712.
  • NAGASAWA M, IMAI M, IMAI K et al.: In vivo class switch of B cells after cord blood stem cell transplantation in severe combined immune deficient (SCID) patient. Am. J. Hematol. (2000) 65:176-179.
  • BHATTACHARYA A, SLATTER MA, CHAPMAN CE et al.: Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant. (2005) 36:1-5.
  • ORTAGA J, IONESCU I, ROCHA V et al.: Unrelated cord blood transplantation in children with primary immunodeficiencies. Bone Marrow Transplant. (2005) 35(Suppl. 2):S57-S58.
  • ROCHA V, SANZ G, GLUCKMAN E: Umbilical cord blood transplantation. Curr. Opin. Hematol. (2004) 11:375-385.
  • WAGNER JE, KERNAN NA, STEINBUCH M, BROXMEYER HE, GLUCKMAN E: Allogeneic sibling umbilical cord blood transplantation in children with malignant and non malignant disease. Lancet (1995) 346:214-219.
  • GENNERY AR, DICKINSON AM, BRIGHAM K et al.: CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center. Cytotherapy (2001) 3:221-232.
  • THOMSON BG, ROBERTSON KA, GOWN D et al.: Analysis of engraftment, graft versus host disease, and immune recovery following unrelated donor cord blood transplantation. Blood (2000) 96:2703-2711.
  • SCHWINGER W, URBAN CH, LACKNER H et al.: Unrelated 5/6 locus matched umbilical cord blood transplantation in a 23 month old child with hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. (1998) 22:393-396.
  • GROSS TG, FILIPOVICH AH, CONLEY ME et al.: Cure of X linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant. (1996) 17:741-744.
  • KERNAN NA, SCHROEDER ML, CIAVARELLA D, PRETI RA, RUBINSTEIN P, O’REILLY RJ: Umbilical cord blood infusion in a patient for correction of Wiskott-Aldrich syndrome: Blood Cells (1994) 20:245-248.
  • MINO E, KOBAYASHI R, YOSHIDA M, SUZUKI Y, YAMADA M, BOYASHI K: Umbilical cord blood stem cell transplantation from unrelated HLA matched donor in an infant with severe congenital neutropenia. Bone Marrow Transplant. (2004) 33:969-971.
  • MINEGISHI M, OHASHI Y, KUMAKI S et al.: Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein-Barr virus associated hemophagocytic lymphohistiocytosis. Bone Marrow Transplant. (2001) 27:883-886.
  • BENITO A, DIAZ MA, ALONSO F, FONTÁN G, MADERO L: Successful unrelated umbilical cord blood transplantation in a child with Omenn’s syndrome. Pediatr. Hematol. Oncol. (1990) 16:361-366.
  • KNUTSON AP, STEFFEN M, WASSMER K, WALL DA: Umbilical cord blood transplantation in Wiskott Aldrich syndrome. J. Pediatr. (2003) 142:519-523.
  • MEYER-BAHLBURG A, WINKLER J, MEERBACK A et al.: Fatal late onset EBV associated post transplant lymphoproliferative disease after umbilical cord blood transplantation due to persistent mixed chimerism and severe delay in T cell recovery in a patient with Omenn’s syndrome. Bone Marrow Transplant. (2004) 34:283-284.
  • STARY J, BARTUNKOVA J, KOBYLKA P et al.: Successful HLA-identical sibling cord blood transplantation in a 6-year-old boy with leukocyte adhesion deficiency syndrome. Bone Marrow Transplant. (1996) 18:249-252.
  • VOWELS M, TANG RL, BERDOUKAS V et al.: Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord blood stem cells. N. Engl. J. Med. (1993) 329:1623-1625.
  • ZIEGNER UH, OCHS HD, SCHANEN C et al.: Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J. Pediatr. (2001) 138:570-573.
  • KURTZBERG J, LAUGHLIN M, GRAHAM ML et al.: Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N. Engl. J. Med. (1996) 335:157-166.
  • TOMIZAWA D, AOKI Y, NAGASWA M et al.: Novel adopted immunotherapy for mixed chimerism after unrelated cord blood transplantation in Omenn syndrome. Eur. J. Haematol. (2005) 75:441-444.
  • TOUBO T, SUGA N, OHGA S et al.: Successful unrelated cord blood transplantation for Epstein-Barr virus associated lymphoproliferative disease with hemophagocytic syndrome. Int. J. Hematol. (2004) 80:458-462.
  • VIBHAKER R, RADHI M, RUMELHART S, TATMAN D, GOLDMAN T: Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant. (2005) 36:855-861.
  • BUCKLEY RA, FISCHER A: Bone marrow transplantation for primary immunodeficiency diseases. In: Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. Ochs HD, Smith CI, Puck JE (Eds), Oxford University Press, New York, USA (1999):459-475.
  • SLATTER MA, BHATTACHARYA A, FLOOD TJ, ABINUN M, CANT AJ, GENNERY AR: Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr. Blood Cancer (2005) (In Press).
  • SHEN BJ, HOU HS, ZHANG HQ, SUI XW: Unrelated, HLA-mismatched multiple human umbilical cord blood transfusion in four cases with advanced solid tumors: initial studies. Blood Cells (1994) 20:285-292.
  • WEINREB S, DELGADO JC, CLAVIJO OP et al.: Transplantation of unrelated cord blood cells. Bone Marrow Transplant. (1998) 22:193-196.
  • DE LIMA M, ST JOHN LS, WIEDER ED et al.: Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br. J. Haematol. (2002) 119:773-776.
  • BARKER JN, WEISDORF DJ, DEFOR TE et al.: Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood (2005) 105:1343-1347.
  • FERNANDEZ MN, REGIDOR C, CABRERA R et al.: Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor. Exp. Hematol. (2003) 31:535-544.
  • KIM DW, CHUNG YJ, KIM TG, KIM YL, OH IH: Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation. Blood (2004) 103:1941-1948.
  • CASTELLO S, PODESTÁ M, MENDITTO VG et al.: Intra-bone marrow injection of bone marrow and cord blood cells: an alternative way of transplantation associated with a higher seeding efficiency. Exp. Hematol. (2004) 32:782-787.
  • MOEZZI L, POURFATHOLLAH AA, ALIMOGHADDAM K, SOLEIMAN M, ARDJIMAND AR: The effect of cryopreservation on clonogenic capacity and in vitro expansion potential of umbilical cord blood progenitor cells. Transplant. Proc. (2005) 37:4500-4503.
  • SHPALL EJ, QUINONES R, GILLER R et al.: Transplantation of ex vivo expanded cord blood. Biol. Blood Marrow Transplant. (2002) 8:368-376.
  • JAROSCAK J, GOLTRY K, SMITH A et al.: Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a Phase I trial using the AastromReplicell system. Blood (2003) 101:5061-5067.
  • DA SILVA CL, GONCALVES R, CRAPNELL KB et al.: A human stromal-based serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp. Hematol. (2005) 33:828-835.
  • HAQUE T, WILKIE GM, TAYLOR C et al.: Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet (2002) 360:436-442.
  • COBBOLD M, KHAN N, POURGHEYSARI B: Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. (2005) 202:379-386.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.